Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...

Thomas Smith, an analyst from Leerink Partners, reiterated the Buy rating on Cartesian Therapeutics (RNAC – Research Report). The ...

DOHA: According to the EY MENA IPO Eye Q3 2024 report, listings in the MENA region marked a significant year-on-year (YoY) ...

Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Celldex (CLDX – Research Report). The associated price ...

KSA dominated listing activity with three IPOs The third quarter saw the region’s first non-GCC listing this year in Egypt ...

Welcome to Amplitude's third quarter 2024 earnings conference call. I'm Yaoxian Chew, vice president of investor relations.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $62.5, a high ...

November 6, 2024MaxCyte, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.13. Operator: Hello ...

Introduction Postpartum haemorrhage (PPH) remains the leading cause of maternal death. Yet there is a lack of clarity around ...

Tamkeen Human Resources Company, Arabian Company for Agricultural and Industrial Investments, and Nice One Beauty Digital ...

On Day One, President Trump must take immediate action to protect migrant children by completely overhauling the Office of ...

Even after the cleanup, some of that material settled to the bottom, where it remains. Now fossil fuels again figured in the ...